← All trials
NCT04403347
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2020
- Primary completion
- Jun 30, 2021
- Completion date
- Sep 30, 2021
- First posted
- May 27, 2020
- Last posted
- May 28, 2020
- Enrollment
- 180
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Chinese Academy of Medical SciencesLead sponsor
- Chinese Academy of Medical SciencesOverall official - principal investigator
- Chinese Academy of Medical SciencesReponsible party - principal investigator
- National Natural Science Foundation of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.